These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27177836)

  • 21. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis.
    Bellemain-Appaix A; Kerneis M; O'Connor SA; Silvain J; Cucherat M; Beygui F; Barthélémy O; Collet JP; Jacq L; Bernasconi F; Montalescot G;
    BMJ; 2014 Oct; 349():g6269. PubMed ID: 25954988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
    Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
    J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.
    Laine M; Toesca R; Berbis J; Frere C; Barnay P; Pansieri M; Peyre JP; Michelet P; Bessereau J; Camilleri E; Helaf O; Camaleonte M; Paganelli F; Dignat-George F; Bonello L
    Thromb Res; 2013 Jul; 132(1):e15-8. PubMed ID: 23726090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?
    Zacharia E; Zacharias K; Papamikroulis GA; Bertsias D; Miliou A; Pallantza Z; Papageorgiou N; Tousoulis D
    Curr Med Chem; 2020; 27(27):4440-4468. PubMed ID: 31838988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura.
    Sewify EM; Sayed D; Abdel Aal RF; Ahmad HM; Abdou MA
    Thromb Res; 2013 Feb; 131(2):e59-63. PubMed ID: 23245653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.
    Alcock RF; Yong AS; Ng AC; Chow V; Cheruvu C; Aliprandi-Costa B; Lowe HC; Kritharides L; Brieger DB
    Int J Cardiol; 2013 Aug; 167(4):1343-6. PubMed ID: 22534045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
    Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R
    J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Serum Angiopoietin-like Protein 2 in Patients with Acute Coronary Syndrome.
    Wang Z; Zheng H; Chen H; Lin X; Chen J; Wang L; Bao W; Lin X; Huang M; Luo Z
    Arch Med Res; 2015 May; 46(4):257-64. PubMed ID: 25999029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome.
    Pang H; Zhang C; Liu F; Gong X; Jin X; Su C
    Med Intensiva; 2017 Nov; 41(8):475-482. PubMed ID: 28038785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
    Leonardi S; Lopes RD; Steg PG; Abnousi F; Menozzi A; Prats J; Mangum S; Wilson M; Todd M; Stone GW; Gibson CM; Hamm CW; Price MJ; White HD; Harrington RA; Bhatt DL; Mahaffey KW
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):158-165. PubMed ID: 27485140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome.
    Colombo G; Gertow K; Marenzi G; Brambilla M; De Metrio M; Tremoli E; Camera M
    Thromb Res; 2011 Aug; 128(2):161-8. PubMed ID: 21420725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical validation of a flow cytometric protocol for quantification of platelet microparticles in dogs.
    Cremer SE; Krogh AKH; Hedström MEK; Christiansen LB; Tarnow I; Kristensen AT
    Vet Clin Pathol; 2018 Jun; 47(2):186-196. PubMed ID: 29601099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome.
    Xie H; Zhang Z; Chen L; Zhang P; Cui Y; Liu H; Ma H; Jiang Y; Wang Y; Yang L; Wu H; Cui L
    Coron Artery Dis; 2017 Dec; 28(8):683-689. PubMed ID: 28731888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The correlation between plasma tissue factor and interleukin 18 and their significance in patients with acute coronary syndrome.
    Li Q; Kuang Y; Qiu J; Zhang X; Ruan Y; Li Z
    Cardiovasc Toxicol; 2015 Jul; 15(3):276-82. PubMed ID: 25427791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of initial clinical presentation on clopidogrel low response.
    Landel JB; Bauters A; Delhaye C; Bonello L; Sudre A; Susen S; Bauters C; Lablanche JM; Lemesle G
    Arch Cardiovasc Dis; 2013 Nov; 106(11):593-600. PubMed ID: 24070598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia.
    Wang W; Zuo B; Wang Y; Li X; Weng Z; Zhai J; Wu Q; He Y
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.
    Gresele P; Falcinelli E; Loffredo F; Cimmino G; Corazzi T; Forte L; Guglielmini G; Momi S; Golino P
    Eur Heart J; 2011 Feb; 32(3):316-25. PubMed ID: 21036774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.